WASHINGTON, Nov. 14, 2016 /PRNewswire-USNewswire/ -- SHARE For Cures, a Washington, DC-based non-profit focused on accelerating disease research through consumer data-sharing, today announced a contribution from Cancer Treatment Centers of America ® (CTCA), a national network of five hospitals that serves adult patients who are fighting cancer. Just one month ago, as part of the White House's Cancer Moonshot Initiative, SHARE For Cures launched its data-sharing platform, along with a study aimed to gather a better understanding of the real-world use of novel cancer immunotherapy drugs. SHARE For Cures' new SHARE platform allows individuals to easily and securely gather their clinical, wellness, lifestyle, and patient-reported data. For the study, the SHARE platform also collects information about cancer immunotherapy use, side effects and benefits. Once gathered, the data will enable researchers to better understand how these new therapies are being used outside of clinical trials, as well as the health impact of these specific drugs on real-world patients. "We are thrilled with the success of our platform and the accrual rates our study is achieving in such a short period of time. The generous contribution from CTCA allows us to accelerate our plans to broaden the reach of our platform in oncology, as well as this study," Co-Founder and President Joshua Mann said. "Cancer Treatment Centers of America commends the novel approach SHARE For Cures has taken to accelerate cancer research, and we are happy that we could help support their admirable work in pursuit of the Cancer Moonshot Initiative's goals," said Maurie Markman, MD, President of Medicine and Science at CTCA. In addition to CTCA, financial support for the SHARE platform has been provided by the Connecting Care Fund at St. Joseph Hospital Foundation. The data exchange within the SHARE platform is powered by Human API.